Randomised phase 3 study of S-1 versus capecitabine, with bevacizumab optional in both arms, in the first-line treatment of metastatic colorectal cancer (mCRC), the SALTO study of the Dutch Colorectal Cancer Group. (February 2017)

• Record Type: Journal Article
• Authors: Kwakman, J.J.M.; Simkens, L.H.J.; Van Rooijen, J.M.; Van de Wouw, A.J.; Loosveld, O.J.L.; Creemers, G.J.M.; Hendriks, M.P.; Los, M.; Van Alphen, R.J.; Polée, M.B.; Muller, E.W.; Van der Velden, A.M.T.; Van Voorthuizen, T.; Koopman, M.; Mol, L.; Van Werkhoven, E.; Punt, C.J.A.
• Is Part Of: European journal of cancer. Volume 72(2017)Supplement 1
• Page Start: S5
• Publication Date: 2017-02
• Subjects: Cancer -- Periodicals; Neoplasms -- Periodicals; Cancer -- Périodiques; Cancer; Tumors; Electronic journals; Periodicals; Electronic journals; 616.994
• DOI: 10.1016/S0959-8049(17)30099-0
• Languages: English
• ISSNs: 0959-8049